Leah Conley
About Leah Conley
Leah Conley is the Head of Global Market Access and HEOR at Travere Therapeutics, a position she has held since 2020. She has extensive experience in market access and commercial operations, having previously worked at AbbVie, Abbott, Amgen, and AveXis, among others.
Current Role at Travere Therapeutics
Leah Conley serves as the Head of Global Market Access and Health Economics Outcomes Research (HEOR) at Travere Therapeutics. She has held this position since 2020, contributing to the company's strategic initiatives in market access and health economics. Her role involves overseeing global market access strategies to ensure that innovative therapies reach patients effectively.
Previous Experience at AbbVie
Leah Conley worked at AbbVie from 2012 to 2018, where she held multiple roles. She served as the Virology and Oncology Director for three years, focusing on market access strategies in these therapeutic areas. Prior to this, she was the Market Access Director for three years, where she developed and implemented strategies to enhance product access.
Professional Background at Abbott
Leah Conley has extensive experience at Abbott, where she held various positions from 2008 to 2012. She was the Chief of Staff and Strategy and Commercial Operations Director for two years, overseeing strategic initiatives. Additionally, she worked as a Product Manager in Cardiovascular and as a Pain Care Specialty Sales Representative. Her tenure at Abbott also included roles as a Market Research Analyst and a Commercial Integration Manager.
Education and Academic Background
Leah Conley earned a Bachelor of Science in Chemical Engineering from the Massachusetts Institute of Technology, completing her studies from 1995 to 1999. She furthered her education at Harvard Business School, where she studied from 2005 to 2007. Her academic background provides a strong foundation for her roles in market access and health economics.
Experience in Other Organizations
Leah Conley has held various positions in other organizations, including Amgen, where she worked as an Immunology Project Manager from 2003 to 2005. She also served as Vice President (ad interim) and Senior Director of Global Market Access at AveXis, Inc. from 2018 to 2020. Additionally, she briefly worked at Endo Pharmaceuticals and Merck, gaining diverse experience in the pharmaceutical industry.